Dog allergen immunotherapy: past, present, and future

被引:23
|
作者
Smith, Derek M. [1 ,2 ]
Coop, Christopher A. [1 ]
机构
[1] Wilford Hall Ambulatory Surg Ctr, Dept Allergy Immunol, San Antonio, TX USA
[2] 2200 Bergquist Dr,Suite 1, Lackland AFB, TX 78236 USA
关键词
DANDER EXTRACTS; CAT-DANDER; IMMUNOLOGICAL CHARACTERIZATION; LIPOCALIN ALLERGEN; INHALANT ALLERGENS; CROSS-REACTIVITY; COMMON ALLERGENS; VACUUM-CLEANERS; F; MITE;
D O I
10.1016/j.anai.2015.12.006
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objective: To review the published medical literature on dog allergy immunotherapy and discuss prior clinical trials, important allergens, extract specifics, and potential future treatment options for dog allergy relevant to the clinical allergist. Data Sources: MEDLINE search was performed using the terms dog, immunotherapy, and allergy limited to human studies from any period. Articles cited in selected studies also were reviewed for appropriateness of inclusion into this review. Study Selections: Publications were included that were original research and fit the topic of dog allergen immunotherapy, specifically articles that investigated prior effectiveness and safety of dog allergen immunotherapy, dog extracts, identification of dog allergens, and current prescribing trends among allergists. Results: Two hundred fifteen articles were initially identified and 60 were reviewed in complete detail for inclusion in this review. The primary focus was placed on the 17 clinical trials that investigated the safety and efficacy of dog immunotherapy and the 19 studies that explored and defined the complex allergenic profile of dog extracts. Conclusion: The medical literature on the use of dog extract immunotherapy in patients with hypersensitivity to dog shows poor and conflicting results of clinical efficacy, which has been attributed to poor-quality extracts and the inherent complex allergenic profile of dogs that remains without a clearly dominant allergen. Published by Elsevier Inc. on behalf of the American College of Allergy, Asthma & Immunology.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 50 条
  • [41] IMMUNOTHERAPY IN CHILDREN - PAST, PRESENT, AND FUTURE .1.
    JOHNSTONE, DE
    [J]. ANNALS OF ALLERGY, 1981, 46 (01): : 1 - 7
  • [42] Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
    Bellati, F.
    Napoletano, C.
    Ruscito, I.
    Visconti, V.
    Antonilli, M.
    Gasparri, M. L.
    Zizzari, I. G.
    Rahimi, H.
    Palaia, I.
    Rughetti, A.
    Panici, P. Benedetti
    Nuti, M.
    [J]. CURRENT MOLECULAR MEDICINE, 2013, 13 (04) : 648 - 669
  • [43] Role of immunotherapy in bladder cancer: past, present and future
    Sabeeh-ur-Rehman Butt
    Laeeq Malik
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 629 - 645
  • [44] Cellular immunotherapy for cancer. Past, present, future
    Alexandros Spyridonidis
    [J]. memo - Magazine of European Medical Oncology, 2012, 5 (2) : 81 - 84
  • [45] Past, present and future targets for immunotherapy in ovarian cancer
    Schwab, Carlton L.
    English, Diana P.
    Roque, Dana M.
    Pasternak, Monica
    Santin, Alessandro D.
    [J]. IMMUNOTHERAPY, 2014, 6 (12) : 1279 - 1293
  • [46] Role of immunotherapy in bladder cancer: past, present and future
    Butt, Sabeeh-ur-Rehman
    Malik, Laeeq
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (04) : 629 - 645
  • [47] CADAVER DOG DETECTION (UK); THE PAST, PRESENT AND FUTURE
    Brooks, Jonathon
    Cordell, Rebecca
    Wilde, Micheal
    Monks, Paul
    Whitehead, Leigh
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2017, 277 : 245 - 245
  • [48] Cancer immunotherapy in clinical practice—the past,present,and future
    Gaurav Goel
    Weijing Sun
    [J]. 癌症, 2014, 33 (09) : 445 - 457
  • [49] Cellular immunotherapy for cancer. Past, present, future
    Spyridonidis, Alexandros
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (02) : 81 - 84
  • [50] IMMUNOTHERAPY IN CHILDREN - PAST, PRESENT, AND FUTURE .2.
    JOHNSTONE, DE
    [J]. ANNALS OF ALLERGY, 1981, 46 (02): : 59 - 66